AstraZeneca Looking At Potential Options for COVID-19 Vaccine Business: Reuters


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


  • AstraZeneca plc (NASDAQ:AZNis reportedly exploring its options for the future of its COVID-19 vaccine business.
  • The Company expects clarity on the matter by the end of 2021.
  • "We are exploring different options," Ruud Dobber, executive vice president and president of BioPharmaceuticals Business Unit, told Reuters about the vaccines business.
  • The Company generated around $894 million from COVID-19 vax sales in Q2.
  • Price Action: AZN shares are up 1.6% at $57.70 during the premarket session on the last check Thursday.
  • Image by Wilfried Pohnke from Pixabay

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechM&ANewsHealth CareRumorsGeneralBriefsCOVID-19 VaccineReuters